Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02676128 · ClinicalTrials.gov registry record · NA

Mobile Health Application to Improve HIV Medication Adherence

A NA study of HIV and Medication Adherence, sponsored by Rhode Island Hospital.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT02676128 is a NA study of HIV and Medication Adherence that has completed, run by Rhode Island Hospital. The registered enrollment target is 80 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02676128, a NA study of HIV and Medication Adherence, has completed, sponsored by Rhode Island Hospital.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

Inadequate adherence to antiretroviral therapy (ART) can impede successful viral suppression and consequently lead to negative health consequences. This study aims to refine and test the efficacy of a mobile health ART adherence application (ARTAA), delivered over a smartphone, with helping individuals improve their ART adherence.

Interventions

  • BEHAVIORAL Twine Collaborative Care Application
  • BEHAVIORAL Information-Motivation-Behavioral Skills Model of ART Adherence

Study Locations (1)

Rhode Island

  • Rhode Island Hospital - Providence

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2016-03
Est. Completion 2020-05
Phase NA

Sponsor

Rhode Island Hospital

130 total trials

What the Registry Record Tells You About NCT02676128

The ClinicalTrials.gov registry entry for NCT02676128 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (82% lower). The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Twine Collaborative Care Application is the first listed.

NCT02676128 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT02676128 about?

NCT02676128 is a clinical study titled "Mobile Health Application to Improve HIV Medication Adherence". Inadequate adherence to antiretroviral therapy (ART) can impede successful viral suppression and consequently lead to negative health consequences. This study aims to refine and test the efficacy of a mobile health ART adherence application (ARTAA), delivered over a smartphone, with helping individu...

What is the current status of trial NCT02676128?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2016-03. Estimated completion is 2020-05.

What conditions does trial NCT02676128 study?

This clinical trial studies the following conditions: HIV, Medication Adherence, Mobile Health.

What interventions are being tested in trial NCT02676128?

The interventions under investigation include: Twine Collaborative Care Application (BEHAVIORAL), Information-Motivation-Behavioral Skills Model of ART Adherence (BEHAVIORAL).

Who is sponsoring clinical trial NCT02676128?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02676128 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.